Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.83% is 42% below its 5-year average of 1.43%, near the low end of its 5-year range (0.10%–37.25%).
As of the fiscal period ended Tuesday, June 30, 2026. 7.56% below its 12-month average of 0.90%.
Reported quarterly debt to assets ratio; no daily interpolation. Q4 FY2026 (2026-06-30): 0.83%.
DEBT TO ASSETS RATIO
0.83%
DEBT TO ASSETS RATIO AVG TTM
0.90%
DEBT TO ASSETS RATIO AVG 3Y
1.59%
DEBT TO ASSETS RATIO AVG 5Y
1.43%
DEBT TO ASSETS RATIO AVG 10Y
1.39%
DEBT TO ASSETS RATIO AVG 15Y
1.34%
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-7.56%
CURRENT VS 3Y AVG
-47.96%
CURRENT VS 5Y AVG
-41.97%
CURRENT VS 10Y AVG
-40.41%
CURRENT VS 15Y AVG
-38.21%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 809 covered companies
CURRENT VS SECTOR MEDIAN
+819.62%
vs the sector median at left
Rezolute, Inc.
Market Cap
$411.65M
Debt to Assets Ratio
0.83%
TTM Avg
0.90%
3Y Avg
1.59%
5Y Avg
1.43%
Market Cap
$412.68M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$410.57M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$410.41M
Debt to Assets Ratio
0.10%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$416.52M
Debt to Assets Ratio
0.33%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$407.51M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$407.12M
Debt to Assets Ratio
0.32%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$420.03M
Debt to Assets Ratio
0.35%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rezolute, Inc. (RZLT) | $411.65M | 0.83% | 0.90% | 1.59% | 1.43% |
| Prothena Corporation plc (PRTA)vs › | $412.68M | 0.02% | N/A | N/A | N/A |
| Strata Critical Medical, Inc. (SRTA)vs › | $410.57M | 0.01% | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $410.41M | 0.10% | N/A | N/A | N/A |
| Myriad Genetics, Inc. (MYGN)vs › | $416.52M | 0.33% | N/A | N/A | N/A |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $407.51M | 0.00% | N/A | N/A | N/A |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $407.12M | 0.32% | N/A | N/A | N/A |
| Neurogene Inc. (NGNE)vs › | $407.07M | 0.03% | N/A | N/A | N/A |
| Senseonics Holdings, Inc. (SENS)vs › | $420.03M | 0.35% | N/A | N/A | N/A |
| Carlsmed, Inc. (CARL)vs › | $403.97M | 0.19% | N/A | N/A | N/A |
Debt/Assets
0.8%
Debt/Equity
0.01
Current Ratio
9.44
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.83% |
| 2026-03-31 | 0.89% |
| 2025-12-31 | 0.93% |
| 2025-09-30 | 0.92% |
| 2025-06-30 | 0.92% |
| 2025-03-31 | 1.87% |
| 2024-12-31 | 1.72% |
| 2024-09-30 | 1.69% |
| 2024-06-30 | 1.68% |
| 2024-03-31 | 2.70% |
| 2023-12-31 | 2.46% |
| 2023-09-30 | 2.07% |
| 2023-06-30 | 2.00% |
| 2023-03-31 | 1.77% |
| 2022-12-31 | 1.57% |
| 2022-09-30 | 0.10% |
| 2022-06-30 | 0.12% |
| 2022-03-31 | 20.84% |
| 2021-12-31 | 17.34% |
| 2021-09-30 | 37.25% |
| 2021-06-30 | 33.84% |
| 2021-03-31 | 1.62% |
| 2020-12-31 | 1.53% |
| 2020-09-30 | 4.71% |
| 2020-06-30 | 3.74% |
| 2020-03-31 | 3.19% |
| 2019-12-31 | 2.56% |
| 2019-09-30 | 2.18% |
| 2019-06-30 | 0.08% |
| 2019-03-31 | 0.06% |
| 2018-12-31 | 1100.77% |
| 2018-09-30 | 386.95% |
| 2018-06-30 | 137.23% |
| 2018-03-31 | 17.99% |
| 2017-12-31 | 0.16% |
| 2017-09-30 | 0.10% |
| 2017-06-30 | 0.09% |
| 2017-03-31 | 0.09% |
| 2016-12-31 | 0.10% |
| 2016-09-30 | 0.60% |
| 2016-06-30 | 0.76% |
| 2016-03-31 | 1.22% |
| 2015-12-31 | 1.53% |
| 2015-09-30 | 1.68% |
| 2015-06-30 | 1.57% |
| 2015-03-31 | 1.66% |
| 2014-12-31 | 2.07% |
| 2014-09-30 | 3.91% |
| 2014-06-30 | 0.81% |
| 2014-03-31 | 32.14% |
| 2013-12-31 | 223.69% |
| 2013-09-30 | 432.22% |
| 2013-06-30 | 338.10% |
| 2013-03-31 | 238.05% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 200.10% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
